LUCIDIN

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H10O5
Molecular Weight	270.2369
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OCC1=C(O)C2=C(C=C1O)C(=O)C3=C(C=CC=C3)C2=O

InChI

InChIKey=AMIDUPFSOUCLQB-UHFFFAOYSA-N

InChI=1S/C15H10O5/c16-6-10-11(17)5-9-12(15(10)20)14(19)8-4-2-1-3-7(8)13(9)18/h1-5,16-17,20H,6H2

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28972744 | https://www.ncbi.nlm.nih.gov/pubmed/25574682 | https://www.ncbi.nlm.nih.gov/pubmed/2070492 | https://www.ncbi.nlm.nih.gov/pubmed/9886573

Lucidin-3-O-primeveroside (LuP) is an anthraquinone derivative present in Rubia tinctorum L. (madder root), which has been used as a coloring agent and food additive. LuP can be metabolically converted to genotoxic compound lucidin, which subsequently forms lucidin-specific N2-2'-deoxyguanosine (N2-dG) and N6-2'-deoxyadenosine (N6-dA) DNA adducts. Lucidin is mutagenic and carcinogenic in rodents but has low carcinogenic risks in humans. Lucidin adduct destabilizes DNA structure and reduces fidelity and processivity of DNA synthesis.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
DNA 278 Target ID: CHEMBL2311221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28972744 \| https://www.ncbi.nlm.nih.gov/pubmed/25574682 \| https://www.ncbi.nlm.nih.gov/pubmed/2070492 \| https://www.ncbi.nlm.nih.gov/pubmed/9886573	Binding Agent 1064

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2578

PubMed

Title	Date	PubMed
Carcinogenicity and DNA adduct formation observed in ACI rats after long-term treatment with madder root, Rubia tinctorum L.	1998 Dec	9886573
Lucidin type anthraquinone glycosides from Putoria calabrica.	2002 May	12036036
Identification and quantification of the constituents of madder root by gas chromatography and high-performance liquid chromatography.	2006 Nov 10	16962601
Chemical constituents of Morinda citrifolia roots exhibit hypoglycemic effects in streptozotocin-induced diabetic mice.	2008 May	18451522
Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity?	2009	20107583
1,3-Dihydr-oxy-2-methoxy-methyl-9,10-anthraquinone from Rennellia elliptica Korth.	2009 May 29	21583274
Anthraquinones from the roots of Knoxia valerianoides inhibit the formation of advanced glycation end products and rat lens aldose reductase in vitro.	2010 Feb	20195820
Chemical structure determination of DNA bases modified by active metabolites of lucidin-3-O-primeveroside.	2010 Jan	20000472
Determination of lucidin-specific DNA adducts by liquid chromatography with tandem mass spectrometry in the livers and kidneys of rats given lucidin-3-O-primeveroside.	2012 May 21	22494063

Patents

Sample Use Guides

In Vivo Use Guide

Male Parkes mice were treated orally for 4 days with lucidin (2 mg/d) and DNA was isolated from liver, kidney, duodenum and colon. Analysis by 32P-postlabelling revealed that lucidin formed DNA adducts in all the tissues examined but that the adduct patterns were organ-specific.

Route of Administration: Oral

In Vitro Use Guide

Lucidin was active against Entamoeba histolytica (MIC 31.25 μg/mL) and Giardia intestinalis (MIC 7.8 μg/mL).

Name

Type

Language

LUCIDIN

Common Name

English

9,10-ANTHRACENEDIONE, 1,3-DIHYDROXY-2-(HYDROXYMETHYL)-

Systematic Name

English

HENINE

Common Name

English

DIHYDROXY-2-(HYDROXYMETHYL)ANTHRAQUINONE, 1,3-

Systematic Name

English

NSC-30546

Code

English

1,3-DIHYDROXY-2-(HYDROXYMETHYL)ANTHRAQUINONE

Systematic Name

English

LUCIDIN [HSDB]

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID10197278